![Bettina Cockroft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bettina Cockroft
Director/Board Member at
ANNEXON, INC.
Net worth: 5 $ as of 31/05/2026
Profile
Bettina M.
Cockroft is currently an Independent Director at Annexon, Inc. since 2022 and an Independent Director at CNS Pharmaceuticals, Inc. since 2023.
Formerly, served as Chief Medical Officer & Senior Vice President at Sangamo Therapeutics, Inc. from 2019 to 2023, Vice President-Clinical Research at Cytokinetics, Inc. from 2017 to 2019, and Chief Medical Officer at Auris Medical AG from 2013 to 2016.
Education includes a doctorate from the University of Genoa and an MBA from MIT Sloan School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/04/2026 | 1 ( 0% ) | 5 $ | 31/05/2026 | |
ANNEXON, INC. -.--% | 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Bettina Cockroft active positions
| Companies | Position | Start |
|---|---|---|
| ANNEXON, INC. | Director/Board Member | 20/01/2022 |
| CNS PHARMACEUTICALS, INC. | Director/Board Member | 08/05/2023 |
Former positions of Bettina Cockroft
| Companies | Position | End |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 16/05/2023 |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01/09/2019 |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Chief Tech/Sci/R&D Officer | 01/09/2016 |
Training of Bettina Cockroft
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
University of Genoa
 University of Genoa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auris Medical AG
Auris Medical AG Medical SpecialtiesHealth Technology Manufactures electronic devices for ear disorders | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CNS Pharmaceuticals, Inc.
 CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
- Stock Market
- Insiders
- Bettina Cockroft
